首页> 外国专利> Use of annexine as lupus anticoagulation controle or standard in coagulation tests

Use of annexine as lupus anticoagulation controle or standard in coagulation tests

机译:在血浆凝结试验中使用膜联蛋白作为狼疮抗凝对照品或标准品

摘要

Control and/or calibration plasma for use in clotting tests contains one or more annexins to simulate lupus anticoagulant. Also claimed is a clotting test using a plasma as above, where the annexin concentration is such that the clotting time or activity is outside the normal range. Also claimed is a method for testing the phospholipid dependence of the increase in clotting time caused by adding one or more annexins to natural plasma, in which phospholipids are added to the assay mixture "via the reagent, by addition of the sample or separate addition with or without preincubation of the sample with the phospholipid".
机译:用于凝结测试的对照和/或校准血浆包含一种或多种模拟狼疮抗凝剂的膜联蛋白。还要求保护的是使用上述血浆进行的凝结试验,其中膜联蛋白的浓度应使凝结时间或活性超出正常范围。还要求保护一种用于测试由于在天然血浆中添加一种或多种膜联蛋白而导致的凝血时间增加的磷脂依赖性的方法,其中通过“通过试剂,通过添加样品或单独添加”将磷脂添加至测定混合物中。或不将样品与磷脂一起预孵育”。

著录项

  • 公开/公告号EP0898168A2

    专利类型

  • 公开/公告日1999-02-24

    原文格式PDF

  • 申请/专利权人 DADE BEHRING MARBURG GMBH;

    申请/专利号EP19980113045

  • 发明设计人 KRAUS MICHAEL DR.;

    申请日1998-07-14

  • 分类号G01N33/48;

  • 国家 EP

  • 入库时间 2022-08-22 02:19:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号